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Background: Brachial artery FMD is widely used as a non-invasive measure of endothelial function.
Adherence to expert guidelines is believed to be of vital importance to obtain reproducible measure-
ments. We conducted a systematic review of studies reporting on the reproducibility of the FMD in order
to determine the relation between adherence to current expert guidelines for FMD measurement and its
reproducibility.
Methods: Medline-database was searched through July 2015 and 458 records were screened for FMD
reproducibility studies reporting the mean difference and variance of repeated FMD measurements. An
adherence score was assigned to each of the included studies based on reported adherence to published
guidelines on the assessment of brachial artery FMD. A Typical Error Estimate (TEE) of the FMD was
calculated for each included study. The relation between the FMD TEE and the adherence score was
investigated by means of Pearson correlation coefﬁcients and multiple linear regression analysis.
Results: Twenty-seven studies involving 48 study groups and 1537 subjects were included in the ana-
lyses. The adherence score ranged from 2.4 to 9.2 (out of a maximum of 10) and was strongly and
inversely correlated with FMD TEE (adjusted R2 ¼ 0.36, P < 0.01). Use of automated edge-detection
software, continuous diameter measurement, true peak diameter for %FMD calculation, a stereostatic
probe holder, and higher age emerged as factors associated with a lower FMD TEE.
Conclusions: These data demonstrate that adherence to current expert consensus guidelines and
applying contemporary techniques for measuring brachial artery FMD decreases its measurement error.
© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
The endothelium is a key regulator of vascular homeostasis and
endothelial dysfunction is an early manifestation of atherosclerosis
[1]. Currently, the most widely used technique to study endothelial
function in vivo is the ﬂow-mediated dilation (FMD) of the brachial
artery. This is a non-invasive, ultrasound-based method whichRadboud University Medical
. Thijssen).
r Ireland Ltd. This is an open accescorrelates with endothelial function of the coronary arteries [2,3]
and independently predicts cardiovascular disease (CVD) [4,5].
The technique is attractive as a surrogate end-point, especially
since changes in FMD can be detected across a relatively short
timeframe [6]. Despite its popularity, minor changes in the meth-
odological approach may critically impact variability and decrease
reproducibility of the FMD response [7e9].
Previous expert consensus guidelines have made important
contributions to standardize the technical approach and to set
minimum standard requirements for FMD measurements [10,11].
However, not all studies on FMD apply these recommendations, ors article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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reproducibility of FMDmeasurements is currently unclear, but may
importantly contribute to the measurement error of the FMD
technique Furthermore, little is known about the relative impor-
tance of the individual aspects of the expert-consensus guidelines
to contribute to the reproducibility of the FMD. Better quantitative
data on this matter can help reduce variation within and between
studies, which will increase the statistical power of studies on FMD
to detect changes and, subsequently, decrease chances for type II
errors.
In light of these considerations, we hypothesized that adherence
to expert consensus guidelines is related to better reproducibility of
FMD measurements [10,11]. Therefore, we performed a systematic
search for published studies that reported data on reproducibility
of FMD measurements, and investigated the relation between (full
or partial) adherence to current expert consensus guidelines and
reproducibility of the FMD. Secondly, we explored which subject-




The MEDLINE bibliographic database was searched (January
2000 through July 2015) for studies that assessed the reproduc-
ibility of the FMD using the following search terms: “ﬂow mediated
dilation”, “ﬂow mediated dilatation”, “ﬂow mediated vasodilation”,
“ﬂow mediated vasodilatation”, “endothelial function”, “endothelial
dysfunction”, “FMD”, “FMV”, “brachial artery”, “reproducibility”,
“reliability”, “repeatability”, “coefﬁcient of variation”, “CV”, and
“variance”. The search was limited to studies in human adults
published in the English language. Additionally, we supplemented
the search by hand-searching references of included studies and
relevant reviews and meta-analyses on this topic.
2.2. Selection of studies
Included studies were identiﬁed by means of a two-step selec-
tion process. During the ﬁrst step, two reviewers (ACCMvM, AG)
independently screened titles, abstracts and keywords of publica-
tions to identify potentially eligible studies. Studies were included
if the mean difference and variance of repeated FMD measure-
ments of the brachial artery were reported. During step 2 of the
selection, both reviewers examined the full text of these publica-
tions to gauge eligibility based on two additional inclusion criteria:
FMD was determined through noninvasive ultrasound imaging,
and a reactive hyperaemia protocol (with an ischemia duration of
4e5 min) was used to elicit the shear stress stimulus required for
FMD. Thus, studies that adopted (ischemic) hand-grip exercise,
passive movement and/or skin warming protocols to elicit
(brachial) artery dilation were not included in our analysis. In cases
of discrepancy between the reviewers, eligibility was discussed
along with a third reviewer (DHJT) until consensus was reached.
2.3. Data extraction
2.3.1. Study and subject characteristics
A standardized data collection sheet was used to extract general
publication details (author, year of publication, country) and spe-
ciﬁc study- and subject characteristics: number of subjects, mean
age (in years); CVD risk status of the study population (deﬁned as
presence of diagnosed CVD, hypertension or diabetes); baseline
brachial artery diameter (in mm); % brachial artery FMD and its
associated variance for each repeated measurement; and the meanabsolute difference between repeated FMD measurements and its
associated variance.
2.3.2. Adherence to guidelines
We extracted information from the methods sections of the
individual papers to assess the adherence to current expert-
consensus guidelines. Based on recent guidelines [11], we scored
each individual study on the reporting of 19 different factors which
were divided over 4 categories. The categories were related to: 1.
Subject preparation (10 items), 2. Image acquisition (4 items), 3.
Data analysis (3 items), and 4. Laboratory (2 items). Before per-
forming the systematic literature search, values were assigned to
each factor proportional to its perceived importance for valid
assessment of the FMD. This was done through expert consensus
discussion within the Working Group (AG, LG and DHJT) [12]. The
“Adherence Score” that could be assigned to a study ranged from 0 to
10 points, depending on how many of the 19 different factors that
were reported. In addition, we counted the number of previous
studies on FMD published by the principal author of each study
included in the systematic review. This number served as a mea-
sure of the perceived experience in FMD measurements for each
centre at the time of publication of the reproducibility data
included here.
2.4. Statistical analysis
Reported measures of FMD reproducibility varied between
studies. Many studies presented the coefﬁcient of variation (CV) of
repeated measurements, although this measure was calculated in a
number of different ways, precluding direct comparisons. Measures
of reproducibility included the technical error of the measurement
(TEM), Pearson- and intraclass correlation coefﬁcients (ICC), and
limits of agreement. In order to make valid comparisons between
studies, we deﬁned as primary outcome measure the typical error
of estimate (TEE) of FMD, which is calculated as standard deviation
of the paired differences/√2 [13].
Data are presented as mean ± SD or median (range) as appro-
priate for continuous variables and as frequencies for categorical
variables. FMD TEE data were highly skewed (Shapiro-Wilk test,
P < 0.0001) and were log transformed prior to the analyses. Re-
lations between log-FMD TEE and continuous variables were
determined by Pearson correlation coefﬁcients analysis. For cate-
gorical variables, the statistical signiﬁcance of differences in FMD
TEE between different levels were assessed by the Mann-Whitney
U test. Signiﬁcant correlates were entered in a multivariate linear
regression analyses with backward elimination to identify inde-
pendent predictors of FMD TEE. All analyses were conducted using
JMP version 11.0 (SAS Institute Inc., Cary, NC, USA).
3. Results
Our systematic search identiﬁed 446 potentially relevant pub-
lications and an additional 12 were obtained through review of
references of included studies, relevant reviews andmeta-analyses.
Twenty-seven studies [14e40] with 48 relevant study groups met
our inclusion criteria and were included in our analysis (Fig. 1).
Characteristics of the included study groups are presented in
Table 1. The 48 study groups comprised a total of 1537 subjects
(mean sample size 32; range, 8e135) with a mean age of 41.5 years
(range, 22e79 years). Eleven study groups included subjects with
increased CVD risk, i.e. presence of diagnosed CVD, hypertension or
diabetes. The other remaining 37 study groups consisted of healthy
subjects. The time between repeated FMD measurements ranged
from 25 min to 9 months. Mean baseline brachial diameter was
3.9 mm (range, 3.5e4.7 mm) and mean baseline FMD (i.e. this ﬁrst
Fig. 1. Flow diagram of the study selection procedure.
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The FMD TEE ranged from 0.33 to 4.83% across study groups, with a
mean value of 1.4%. The level of experience for each centre at the
time of publication of the reproducibility study in question varied
widely (number of previously published studies on FMD ranging
from 0 to 71, median of 3).
3.1. Methodology-related factors versus variation in FMD
There was considerable variation in the methodological factors
between studies. Adherence scores ranged from 2.4 to 9.2, with a
mean of 5.3 (out of a maximum of 10). The adherence score was
inversely correlated with log FMD TEE (adjusted R2¼ 0.36, P < 0.01,
Fig. 2).
To explore the impact of the different aspects of the adherence
score on the FMD TEE, we compared the FMD TEE between
adherence (Yes vs No) to various methodological variables. Statis-
tically signiﬁcant differences in FMD TEE were found for use of the
true peak diameter to calculate %FMD, continuous brachial artery
diameter measurement over the cardiac cycle, use of automated
edge detection software and smoking cessation prior to measure-
ments (Table 2).
3.2. Subject-related factors versus variation in FMD
For the remaining methodology related factors and subject
characteristics, there were weak, but statistically signiﬁcant cor-
relations of log FMD TEE with age (adjusted R2 ¼ 0.18, P < 0.01)
and with baseline FMD (adjusted R2 ¼ 0.11, P ¼ 0.013). In addition,
FMD TEE was signiﬁcantly smaller in the subgroup of studies that
applied a stereostatic probe holder, and in studies performed by
groups with more experience according to number of earlier pub-
lications on FMD. The %FMD TEE of studies above and below the
median duration between repeatedmeasurements (7 days) was not
signiﬁcantly different (Table 3), and there was no correlation be-
tween %FMD TEE and the time between repeated measurements
(adjusted R2 ¼ 0.02, P < 0.75).
We constructed a stepwise multivariate regression model with
log FMD TEE as the dependent variable and all factors that signif-
icantly inﬂuenced FMD TEE based on the individual analyses
(adherence score, age, baseline FMD, probe holder and previousexperience). The stepwise multivariate regression model predicted
51% of the variability in log FMD TEE. Adherence score (b ¼ 0.16),
age (b ¼ 0.01) and probe holder (b ¼ 0.19) remained as statis-
tically signiﬁcant (P < 0.05) predictors in the model (Table 4).4. Discussion
In the recent years the measurement of FMD in the brachial
artery has been associated with predictive capacity for future CVD
events. Despite this, and the relatively straightforward and non-
invasive approach to its measurement, the clinical use of the FMD
is hampered by its sensitivity to variations in methodology.
Our systematic analysis of previous studies that explored FMD
reproducibility provides us with a number of novel observations.
First, we found considerable variation in the methodology applied
to measure FMD and consequently, differences between studies in
the adherence to current expert consensus guidelines. Secondly,
these data show a robust inverse association between adherence to
the guidelines and FMD reproducibility, with higher adherence to
guidelines being related to smaller variation in FMD. Thirdly, we
identiﬁedmethodological factors that were associatedwith smaller
variation in FMD. Speciﬁcally, the use of automated edge detection
software, continuous measurement of brachial artery diameter
across the cardiac cycle, calculating %FMD by means of the true
peak diameter and use of a stereostatic probe holder were related
to a better reproducibility. Taken together, our study provides
strong scientiﬁc data that highlight the importance of rigorous
application of standardized contemporary methodology to reduce
measurement error of FMD and, consequently, improve its use in
(pre)clinical studies.
To our knowledge, no previous study has explored the (relative)
importance of adherence to expert consensus guidelines for mea-
sures of vascular health, including frequently used techniques like
intima-media thickness, pulse wave velocity, and ﬁnger photo-
plethysmography. Taking all studies on the reproducibility of the
FMD together, involving 1537 subjects, we found a TEE of 1.4%
based on an average FMD of 7.1%. This indicates an overall good-to-
acceptable reproducibility of the FMD. However, signiﬁcant varia-
tion was observed between studies, with adherence to the expert
consensus guidelines representing an important determinant of
this variation. Our data suggests that roughly 36% of the variation in
Table 1
General characteristics of the FMD reproducibility studies included in the systematic review.











Kanahara 2014 [14] Healthy 32 40 7.90 3.83 14 1.28
Charakida 2013 [15] CVD, Diabetes 67 61 4.10 4.55 2 0.94
Charakida 2013 67 61 4.10 4.60 90 1.04
Charakida 2013 67 61 4.10 4.65 270 1.47
Ghiadoni 2012 [16] Healthy 135 32 6.52 3.53 1 h 0.83
Ghiadoni 2012 135 32 6.52 3.55 30 1.15
Onkelinx 2012 [17] CVD 18 68 6.80 3.92 0.5 h 0.94
Onkelinx 2012 18 68 7.13 3.91 2 0.88
Lima 2010 [18] Healthy 31 25 13.17 3.57 2 2.91
Thijssen 2009 [19] Healthy 10 24 6.83 4.28 0.5 h 0.89
Donald 2008 (true peak
diameter) [20]
Healthy 32 43 8.10 3.70 6 h 0.79
Donald 2008 (true peak
diameter)
34 43 7.50 3.70 7 0.79
Donald 2008 (true peak
diameter)
37 43 8.10 3.75 30 0.53
Donald 2008 (true peak
diameter)
35 43 7.80 3.80 90 0.74
Donald 2008 (60 s) 32 43 7.30 3.70 6 h 1.08
Donald 2008 (60 s) 34 43 6.70 3.70 7 0.95
Donald 2008 (60 s) 37 43 7.50 3.75 30 0.63
Donald 2008 (60 s) 35 43 7.10 3.80 90 0.87
Simova 2008 [21] CVD,
Hypertension
40 62 6.05 3.84 0.25 h 0.85
Craiem 2007 [22] Healthy 10 32 7.60 3.95 1 h 0.80
Craiem 2007 10 32 8.10 3.89 7 0.91
Craiem 2007 CVD 26 44 6.98 3.97 1 h 1.34
Craiem 2007 26 44 5.66 4.15 30 0.96
Harris 2007 [23] Healthy 9 57 7.80 4.11 2 1.32
Meirelles 2007 [24] Healthy 10 33 19.90 3.50 1.5 h 2.70
Meirelles 2007 13 33 16.50 3.55 3 2.50
Donald 2006 [25] Healthy 16 28 7.30 3.55 1 1.63
Harris 2006 [26] Healthy 16 23 9.88 3.74 2 h 0.71
Leeson 2006 [27] Healthy 17 32 4.74 4.05 20 1.22
Elsen 2005 [28] Healthy 15 23 4.61 4.04 1 0.63
Sejda 2005 [29] Healthy 18 28 5.95 4.04 7 3.89
Sejda 2005 18 28 4.23 4.15 7 1.63
Stoner 2004 [30] Healthy 9 23 10.20 3.90 2 3.26
West 2004 [31] Diabetes 18 55 5.57 4.01 7 0.81
West 2004 18 55 5.57 4.01 14 1.07
Sidhu 2002 [32] Healthy 12 36 5.38 3.94 20 0.37
Sidhu 2002 CVD 12 62 1.80 4.29 20 0.33
Beux 2001 [33] Healthy 38 44 6.62 4.41 1 h 1.97
Beux 2001 38 44 4.32 4.41 1 h 1.22
De Roos 2001 [34] Healthy 34 27 4.13 3.90 25 2.01
Herrington 2001 [35] Healthy 127 79 2.63 4.53 7 0.79
Herrington 2001 30 45 7.87 4.35 7 1.46
Woodman 2001 [36] Healthy 24 55 6.60 4.06 7 0.71
Lind 2000 [37] Healthy 10 22 7.40 3.55 2 h 2.19
Lind 2000 10 22 7.40 3.55 21 2.82
Preik 2000 [38] Healthy 8 28 10.60 3.62 20 1.06
Liang 1998 [39] Healthy 30 44 10.80 3.84 18 2.01
Hardie 1997 [40] Healthy 19 36 3.00 3.78 90 4.83
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guidelines alone. The presence of a linear relation between
adherence to the guidelines and variation of the FMD suggests that
measurement error would be further reduced with stricter adher-
ence to the guidelines. Our data also indicate that even with full
adherence to current expert consensus guidelines, some level of
measurement error remains present. Nonetheless, a signiﬁcant
amount of variation in the FMD can be prevented by strong
adherence to guidelines.
Our analysis provides further insight into methodological fac-
tors that determine within-person error of the FMD measurement.
For example, we found that taking the true peak artery diameter
(rather than a ﬁxed time point), continuous diametermeasurement
and automated edge-detection contribute to minimizing mea-
surement error. The importance of these methodological factorshave already been acknowledged in previous work. For example,
Black et al. found that the peak diameter following cuff release
differs between young and older subjects [7]. Consequently,
calculating the FMD% at an arbitrary time point (e.g. 60 s) may lead
to misleading conclusions compared to an approach in which
diameter of the brachial artery is recorded continuously, allowing
for the detection of the true peak dilation. Furthermore, previous
work demonstrated that the adoption of edge-detection software
to perform observer-independent analysis leads to smaller varia-
tion compared to the application of manual calipers, the latter
being highly prone to measurement bias [36,41,42]. Whilst these
studies highlight the importance of considering these factors for
valid use of FMD, the present study also highlights the importance
of considering these factors to lower variation. Therefore, our study
provides an additional rationale to perform continuous assessment
Fig. 2. Linear correlation between the Typical Error of the Flow Mediated Dilation
Estimate (FMD TEE) and adherence to expert guidelines (Adherence Score) in 27
studies (involving 48 study groups) of FMD reproducibility.
Table 2
Relationship of individual components of the adherence score with FMD TEE.
Adherence score characteristic Median (IQR) %FMD TEE
Subject preparation n No n Yes p
Fasting state (>6 h) 21 1.08 (0.83e2.10) 27 0.96 (0.80e1.47) 0.38
No smoking/tobacco consumption prior to measurement (>6 h) 22 0.89 (0.73e1.22) 26 1.30 (0.89e2.55) <0.01
No habitual exercise prior to measurement (>48 h) 31 1.22 (0.89e1.97) 17 0.87 (0.72e1.36) 0.07
No food/beverages that contain alcohol and/or caffeine for >12 h 31 1.06 (0.79e1.97) 17 1.04 (0.82e1.40) 0.6
No polyphenol-rich food/beverages (cocoa, tea, fruit juices) for >18 h 45 1.04 (0.79e1.63) 3 1.15 (0.83e2.91) 0.6
No vitamins for at least 72 h 44 1.05 (0.80e1.63) 4 0.99 (0.68e2.47) 0.8
Vasoactive medications withheld/noted on the morning of the study 26 1.01 (0.79e1.98) 22 1.06 (0.84e1.51) 0.8
Supine position; 15 min rest in a quiet, temperature controlled room 30 1.01 (0.80e1.72) 18 1.10 (0.82e1.60) 1.0
Repeated measurements standardized to timing of the menstrual cycle 36 1.01 (0.79e1.89) 12 1.06 (0.84e1.59) 0.7
Repeated measurements done in ﬁxed time windows (same time of day) 7 1.22 (0.94e1.47) 41 0.96 (0.79e1.80) 0.5
Image acquisition
Diameter measurements recorded continuously over the cardiac cycle 35 1.22 (0.85e2.01) 13 0.88 (0.75e0.95) <0.01
Diameter measurements obtained during end diastole only 15 0.89 (0.79e1.15) 33 1.22 (0.83e2.01) 0.06
Simultaneous acquisition of pulse-wave Doppler velocity signal for quantiﬁcation of shear stimulus 20 1.40 (0.86e2.15) 28 0.94 (0.79e1.21) 0.05
Image analysis
Analysis using automated edge detection and wall tracking software 13 2.19 (1.47e2.87) 35 0.91 (0.79e1.22) <0.01
FMD calculation point (true peak diameter) 17 1.63 (0.94e2.76) 31 0.91 (0.79e1.28) <0.01
Lab data
Use of experienced sonographers reported 20 1.09 (0.73e2.38) 28 1.05 (0.82e1.47) 0.7
Same sonographers paired to same subjects for repeated measurements 8 1.10 (0.86e1.44) 40 1.01 (0.79e1.89) 0.8
P values in bold are signiﬁcant at P ¼ 0.05.
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performing valid and reproducible assessments of the FMD.
Another important observation in our study was that previous
experience of a laboratory with the FMD resulted in a smaller
variation. A potential explanation for this ﬁnding is that experi-
enced laboratories are more likely to demonstrate better adherence
to the expert consensus guidelines. Indeed, when all factors were
included in the ﬁnal regression analysis (including adherence to the
guidelines), previous experience of a laboratory with FMD did not
emerge as an independent predictor of FMD reproducibility.
Another factor that contributed to a smaller variation of the FMD
was the use of a probe holder. The use of such devices is largely
dependent on the personal preference of the laboratory and the
effect on measurement reproducibility is a complex topic, since
highly skilled operators with years of experience are able to
conduct FMD measurements with exceptional reproducibility,regardless of the use of a probe holder [19]. One may speculate that
sonographers' learning curves will likely differ depending on
whether a probe holder is used or not and also depending on the
design and construction of the probe holder itself. Therefore,
despite the signiﬁcant inverse association in our analysis, it remains
difﬁcult to ascertain whether use of a probe holder leads to a
smaller variation in FMD per se. Further studies are needed to
conﬁrm the importance of using a probe holder to reduce vari-
ability of the FMD.
Of the subject-related factors (age, diameter and baseline FMD),
only age contributed independently to the variation in FMD.
Notably, higher age of subjects was associated with a smaller
variation in FMD. Older age is typically associatedwith a lower FMD
[43,44], which may contribute to a smaller (biological) variation
and/or less ability to change in response to hemodynamic stimuli,
consequently leading to a smaller measurement error. However, at
least a previous work suggests the presence of larger variability for
measurements of vascular health in clinical groups. For example,
Craiem et al. found that subjects with CVD, despite comparable
baseline FMD% values, demonstrate a larger coefﬁcient of variation
compared to healthy controls [22]. Our data suggest that the
reproducibility of the FMD may differ between (clinical) groups.Interestingly, the time between repeated measurements did not
signiﬁcantly affect FMD reproducibility in our analyses. This might
seem counter-intuitive, as poorer reproducibility is expected as the
time between repeated measurements increases. Indeed, a recent
study speciﬁcally designed to determine FMD reproducibility over
short (48 h), medium (3 months) and long (9 months) time frames
did ﬁnd poorer reproducibility at 9 months between repeated
measurements [15]. Reproducibility was comparable for the shorter
time periods however, which is in agreement with a recent Italian
multicenter study which found no differences in FMD reproduc-
ibility up to 30 days betweenmeasurements [16]. It should be noted
that there was a large heterogeneity in time between measure-
ments in the included study groups, with the majority ranging
between one and 15 days (n ¼ 32) and some up to 30 (n ¼ 11), 90
(n ¼ 4) and 270 days (n ¼ 1). Excluding these last 16 studies from
the analyses did not appreciably change our ﬁndings our ﬁndings
Table 3
Relationship of subject- and methodology-related characteristics with FMD TEE.
Continuous variables Adjusted Pearson R2 P-values
Age (years) 0.18 <0.01
Baseline FMD (%)a 0.11 0.01
Baseline diameter (mm) 0.02 0.15
Number of subjects (n) 0.001 0.33
Categorical variables Median (IQR) %FMD TTE
n No n Yes P-
values
CVD risk 37 1.15 (0.79e2.01) 11 0.94 (0.85e1.07) 0.31
Distal occlusion cuff
placement
5 2.01 (0.91e2.6) 43 1.04 (0.79e1.47) 0.17
Stereostatic probe holder 18 1.82 (1.02e2.85) 30 0.92 (0.73e1.22) <0.01




18 0.94 (0.81e1.72) 30 1.06 (0.71e1.61) 0.77
P values in bold are signiﬁcant at P ¼ 0.05.
a Baseline FMD refers to the ﬁrst of the two repeated measurements.
b Centre experience was deﬁned as the number of previous studies on FMD
published by the principle author of each included study. The effect of centre
experience was examined by comparing the %FMD TEE of studies below (No) and
above (yes) the median number of previously published FMD studies.
c The effect of the time duration between studies was examined by comparing the
%FMD TEE of studies below (no) and above (yes) the median duration of 7 days.
Table 4
Relation of the adherence score, subject- and methodological factors with the
reproducibility of the FMD measurement.
Stepwise regression analysis (model Adj R2 ¼ 0.51)
Variable b 95% CI P-value
Adherence score (unit) 0.16 0.24; 0.07 <0.01
Age (year) 0.01 0.02; 0.001 0.03
Stereostatic probe holder (yes) 0.19 0.06; 0.33 <0.01
The regression coefﬁcient b represents the increase in the log FMD TEE per unit
increase in each factor. Baseline FMD and Centre experience did not remain in the
model.
P values in bold are signiﬁcant at P ¼ 0.05.
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An obvious limitation of our systematic review is that the degree
of adherence to expert consensus guidelines was assessed from
information as provided in the papers. If a methodological
description omitted one or more of the 19 different scoring factors,
no points were assigned for those factors. As a consequence some
studies with sparse methodological descriptions received lower
scores. Poor methodological reporting might therefore have
confounded our outcomes. It should also be acknowledged that our
estimation of the experience of a laboratory with FMD measure-
ments does not necessarily reﬂect the experience of an individual
sonographer. However, a laboratory more experienced in per-
forming FMD measurements will generally require a level of skill
and training for their sonographers that will meet at least the
standard of their previous work. This highlights the importance of
the level of experience in performing studies with FMD as an
outcome variable. Another limitation is that our analysis on the
relative importance of individual subject- and/or methodology-
related factors could only be based on a between-study compari-
son of factors contributing to the reproducibility of the FMD.
Various other factors may have inﬂuenced this analysis. Therefore,
future studies are necessary to further explore the importance of(some of) the methodology-related factors, including the effects of
factors which we could not examine with the current dataset such
as the observer/analyst, the time of cuff occlusion and changes in
baseline brachial artery diameter.
In conclusion, this systematic review shows that adherence to
current expert consensus guidelines signiﬁcantly reduces mea-
surement error when assessing brachial artery FMD in humans.
Moreover, when adopting the guidelines, we found that the use of
contemporary techniques (i.e. continuous diameter recording,
edge-detection and wall-tracking software and under some cir-
cumstances the use of a probe holder) is crucial to improve
reproducibility of the FMDmeasurement. Considering these factors
will importantly decrease measurement error of the FMD and,
consequently, decrease chances for type II errors in studies that rely
on FMD as their primary outcome parameter. In other words,
ignoring current expert-consensus guidelines causes signiﬁcant
variability of the FMD and, consequently, may lead to spurious
conclusions. This study delivers important insight that should be
taken into account when developing future updates to expert-
consensus guidelines.
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